These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 24829978)
1. Bis-(1,2,3,4-tetrahydroisoquinolinium): a chiral scaffold for developing high-affinity ligands for SK channels. Liégeois JF; Wouters J; Seutin V; Dilly S ChemMedChem; 2014 Apr; 9(4):737-40. PubMed ID: 24829978 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and radioligand binding studies of bis-(8-isopropyl-isoquinolinium) derivatives as ligands for apamin-sensitive sites on cloned SK2 and SK3 channels. Badarau E; Dilly S; Dufour F; Poncin S; Seutin V; Liégeois JF Bioorg Med Chem Lett; 2011 Nov; 21(22):6756-9. PubMed ID: 21978678 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and radioligand binding studies of bis-isoquinolinium derivatives as small conductance Ca(2+)-activated K(+) channel blockers. Graulich A; Dilly S; Farce A; Scuvée-Moreau J; Waroux O; Lamy C; Chavatte P; Seutin V; Liégeois JF J Med Chem; 2007 Oct; 50(21):5070-5. PubMed ID: 17867663 [TBL] [Abstract][Full Text] [Related]
4. Chemical modifications of the N-methyl-laudanosine scaffold point to new directions for SK channels exploration. Badarau E; Dilly S; Wouters J; Seutin V; Liégeois JF Bioorg Med Chem Lett; 2014 Dec; 24(24):5616-5620. PubMed ID: 25466186 [TBL] [Abstract][Full Text] [Related]
5. Electrophysiological characterization of the SK channel blockers methyl-laudanosine and methyl-noscapine in cell lines and rat brain slices. Scuvée-Moreau J; Boland A; Graulich A; Van Overmeire L; D'hoedt D; Graulich-Lorge F; Thomas E; Abras A; Stocker M; Liégeois JF; Seutin V Br J Pharmacol; 2004 Nov; 143(6):753-64. PubMed ID: 15504758 [TBL] [Abstract][Full Text] [Related]
6. Bis-tetrahydroisoquinoline derivatives: AG525E1, a new step in the search for non-quaternary non-peptidic small conductance Ca(2+)-activated K(+) channel blockers. Graulich A; Lamy C; Alleva L; Dilly S; Chavatte P; Wouters J; Seutin V; Liégeois JF Bioorg Med Chem Lett; 2008 Jun; 18(11):3440-5. PubMed ID: 18436444 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and radioligand binding studies of C-5- and C-8-substituted 1-(3,4-dimethoxybenzyl)-2,2-dimethyl-1,2,3,4-tetrahydroisoquinoliniums as SK channel blockers related to N-methyl-laudanosine and N-methyl-noscapine. Graulich A; Scuvée-Moreau J; Seutin V; Liégeois JF J Med Chem; 2005 Jul; 48(15):4972-82. PubMed ID: 16033276 [TBL] [Abstract][Full Text] [Related]
8. New alkyl-lipid blockers of SK3 channels reduce cancer cell migration and occurrence of metastasis. Girault A; Haelters JP; Potier-Cartereau M; Chantome A; Pinault M; Marionneau-Lambot S; Oullier T; Simon G; Couthon-Gourvès H; Jaffrès PA; Corbel B; Bougnoux P; Joulin V; Vandier C Curr Cancer Drug Targets; 2011 Nov; 11(9):1111-25. PubMed ID: 21999627 [TBL] [Abstract][Full Text] [Related]
9. The Bis(1,2,3,4-tetrahydroisoquinoline) Alkaloids Cepharanthine and Berbamine Are Ligands of SK Channels. Vitello R; Taouba H; Derand M; Liégeois JF ACS Med Chem Lett; 2024 Feb; 15(2):215-220. PubMed ID: 38352826 [TBL] [Abstract][Full Text] [Related]
10. The interactions of apamin and tetraethylammonium are differentially affected by single mutations in the pore mouth of small conductance calcium-activated potassium (SK) channels. Dilly S; Philippart F; Lamy C; Poncin S; Snyders D; Seutin V; Liégeois JF Biochem Pharmacol; 2013 Feb; 85(4):560-9. PubMed ID: 23270990 [TBL] [Abstract][Full Text] [Related]
11. Correspondences between the binding characteristics of a non-natural peptide, Lei-Dab7, and the distribution of SK subunits in the rat central nervous system. Aidi-Knani S; Pezard L; Mpari B; Ben Hamida J; Sabatier JM; Mourre C; Regaya I Eur J Pharmacol; 2015 Apr; 752():106-11. PubMed ID: 25704615 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of N-methyl-laudanosine iodide analogues as potential SK channel blockers. Graulich A; Mercier F; Scuvée-Moreau J; Seutin V; Liégeois JF Bioorg Med Chem; 2005 Feb; 13(4):1201-9. PubMed ID: 15670929 [TBL] [Abstract][Full Text] [Related]
13. Identification of a pharmacophore of SKCa channel blockers. Dilly S; Graulich A; Farce A; Seutin V; Liegeois JF; Chavatte P J Enzyme Inhib Med Chem; 2005 Dec; 20(6):517-23. PubMed ID: 16408787 [TBL] [Abstract][Full Text] [Related]
14. Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channels. Gentles RG; Grant-Young K; Hu S; Huang Y; Poss MA; Andres C; Fiedler T; Knox R; Lodge N; Weaver CD; Harden DG Bioorg Med Chem Lett; 2008 Oct; 18(19):5316-9. PubMed ID: 18774291 [TBL] [Abstract][Full Text] [Related]
15. Modulation of small conductance calcium-activated potassium (SK) channels: a new challenge in medicinal chemistry. Liégeois JF; Mercier F; Graulich A; Graulich-Lorge F; Scuvée-Moreau J; Seutin V Curr Med Chem; 2003 Apr; 10(8):625-47. PubMed ID: 12678783 [TBL] [Abstract][Full Text] [Related]
16. New Disaccharide-Based Ether Lipids as SK3 Ion Channel Inhibitors. Berthe W; Sevrain CM; Chantôme A; Bouchet AM; Gueguinou M; Fourbon Y; Potier-Cartereau M; Haelters JP; Couthon-Gourvès H; Vandier C; Jaffrès PA ChemMedChem; 2016 Jul; 11(14):1531-9. PubMed ID: 27278812 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of carbon-11 labeled 1-(3,4-dimethoxybenzyl)-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolinium derivatives as new potential PET SKCa channel imaging agents. Gao M; Wang M; Zheng QH Appl Radiat Isot; 2008 Feb; 66(2):194-202. PubMed ID: 17905592 [TBL] [Abstract][Full Text] [Related]
18. The antidepressant fluoxetine blocks the human small conductance calcium-activated potassium channels SK1, SK2 and SK3. Terstappen GC; Pellacani A; Aldegheri L; Graziani F; Carignani C; Pula G; Virginio C Neurosci Lett; 2003 Jul; 346(1-2):85-8. PubMed ID: 12850554 [TBL] [Abstract][Full Text] [Related]
19. Bis-tetrahydroisoquinoline derivatives: structure analysis of the three stereoisomers of 1,1'-(propane-1,3-diyl)-bis-(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline). Wouters J; Elasaad K; Norberg B; Graulich A; Liégeois JF Eur J Med Chem; 2010 Jul; 45(7):3240-4. PubMed ID: 20381214 [TBL] [Abstract][Full Text] [Related]
20. A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo. Oliván-Viguera A; Valero MS; Coleman N; Brown BM; Laría C; Murillo MD; Gálvez JA; Díaz-de-Villegas MD; Wulff H; Badorrey R; Köhler R Mol Pharmacol; 2015 Feb; 87(2):338-48. PubMed ID: 25468883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]